Learning from POSTAL study: can levothyroxine improve pregnancy outcomes in women with thyroid autoimmunity?
10.3760/cma.j.issn.1000-6699.2018.05.001
- VernacularTitle:POSTAL研究解读:左旋甲状腺素能改善甲状腺自身免疫妇女的妊娠结局吗?
- Author:
Tianpei HONG
1
;
Haining WANG
;
Hongwei GAO
Author Information
1. 100191,北京大学第三医院内分泌科
- Keywords:
Thyroid autoimmunity;
In vitro fertilization and embryo transplantation;
Thyroperoxidase antibody;
Pregnancy outcomes;
Randomized controlled trial
- From:
Chinese Journal of Endocrinology and Metabolism
2018;34(5):359-361
- CountryChina
- Language:Chinese
-
Abstract:
Whether levothyroxine ( LT4 ) treatment improves outcomes following in vitro fertilization and embryo transfer ( IVF-ET) in euthyroid women who have tested positive for thyroid autoantibodies remains unclear. In Pregnancy Outcome Study in enthyroid women with Thyroid Autoimmunity after Levothyroxine ( POSTAL) trial, which was a randomized controlled study involving 600 euthyroid women undergoing IVF-ET who were tested positive for thyroperoxidase antibodies, the miscarriage rate, clinical pregnancy rate and live-birth rate were not significantly different between the LT4 intervention group and control group. Therefore, LT4 treatment did not appear to improve pregnancy outcomes among women with thyroid autoantibodies undergoing IVF-ET.
